Shuhei is an experienced industry leader and advocate for the value of pharmaceutical innovation and importance of access to transformational medicines.
As President and Representative Director of J&J Innovative Medicine Japan, Shuhei is responsible for leading J&J Innovative Medicine’s second largest market globally and is also a member of the Asia Pacific Leadership Team.
Originally from Japan, Shuhei led the J&J Innovative Medicine business in Taiwan from 2019 - 2021, where his focus on talent development and an inclusive culture strengthened the organization and drove significant business growth. During his time in Taiwan, Shuhei was President of the International Research-Based Pharmaceutical Manufacturers Association (IRPMA) and Co-chair of the American Chamber of Commerce in Taiwan’s Pharmaceutical Committee. In these roles, he advocated for innovation in the pharmaceutical industry and the importance of access to innovative healthcare in Taiwan.
Shuhei began his career with Johnson & Johnson in 2004 and has held various roles of increasing responsibility in Asia Pacific and at a global level, including leadership of the J&J Innovative Medicine Japan Immunology and Infectious Diseases business from 2016-2019.
Shuhei holds an undergraduate degree from Dartmouth College and a Master of Business Administration from Duke University.